History of the Concept of Disconnectivity in Schizophrenia

Harvard Review of Psychiatry

Volumn 24, Issue 2, 2016, Pages 80-86

  Coyle, Joseph T ^a   Balu, Darrick T ^a   Puhl, Matthew D ^a   Konopaske, Glenn T ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

dendrites; NMDA receptor; risk genes; schizophrenia; serine racemase

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMPA RECEPTOR; DEXTRO SERINE; DOPAMINE 2 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RACEMASE; GRIN1 PROTEIN, HUMAN; ISOMERASE; NERVE PROTEIN; SERINE RACEMASE;

ALZHEIMER DISEASE; AUDITORY CORTEX; BIPOLAR DISORDER; BRAIN CHEMICAL ANALYSIS; BRAIN CORTEX ATROPHY; BRAIN DISEASE; BRAIN SIZE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONNECTOME; CORPUS CALLOSUM; DEFAULT MODE NETWORK; DENDRITIC SPINE; DIFFUSION TENSOR IMAGING; DNA MICROARRAY; FRACTIONAL ANISOTROPY; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GLUTAMATERGIC SYNAPSE; HIPPOCAMPUS; HUMAN; HUMAN GENOME; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERNEURON; LATERAL PREFRONTAL CORTEX; LINKAGE ANALYSIS; LONG TERM POTENTIATION; NEGATIVE SYNDROME; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER; NEUROCHEMISTRY; NEUROIMAGING; NEUROPATHOLOGY; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; POSTSYNAPTIC DENSITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; SPATIAL LEARNING; SPATIAL MEMORY; SYNAPSE; SYNAPTOGENESIS; TEMPORAL CORTEX; UPREGULATION; VENTRICULAR ENLARGEMENT; ATROPHY; BRAIN CORTEX; GENETICS; META ANALYSIS (TOPIC); METABOLISM; PATHOLOGY;

ATROPHY; CEREBRAL CORTEX; COGNITION DISORDERS; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; META-ANALYSIS AS TOPIC; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEURONS; RACEMASES AND EPIMERASES; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 84962585187     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1097/HRP.0000000000000102     Document Type: Review

References (70)

1. Kety SS,. Biochemical theories of schizophrenia. I. Science 1959; 129: 1528-32.
2. Kety SS,. Biochemical theories of schizophrenia. II. Science 1959; 129: 1590-6.
3. Freeman T,. On Freuds theory of schizophrenia. Int J Psychoanal 1977; 58: 383-8.
4. Wender PH, Rosenthal D, Kety SS, Schulsinger F, Welner J,. Crossfostering. A research strategy for clarifying the role of genetic and experiential factors in the etiology of schizophrenia. Arch Gen Psychiatry 1974; 30: 121-8.
5. Kety SS, Wender PH, Jacobsen B,. Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark. Arch Gen Psychiatry 1994; 51: 442-55.
6. Lehmann HE, Ban TA,. The history of the psychopharmacology of schizophrenia. Can J Psychiatry 1997; 42: 152-62.
7. Corsellis JAN,. Psychoses of obscure pathology. In: Blackwood W, Corsellis JAN,., eds. Greenfields neuropathology. 3rd ed. London: Edward Arnold, 1976: 903-15.
8. Plum F,. Prospects for research on schizophrenia. 3. Neurophysiology. Neuropathological findings. Neurosci Res Program Bull 1972; 10: 384-8.
9. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L,. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924-6.
10. Haug JO,. Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients. Acta Psychiatr Scand 1982; 66: 374-83.
11. Haug JO,. Pneumoencephalographic studies in mental disease. Acta Psychiatr Scand 1962; suppl 38: 1-104.
12. Van Horn JD, McManus IC,. Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle:brain ratio (VBR). Br J Psychiatry 1992; 160: 687-97.
13. Harvey I, Ron MA, Du Boulay G, Wicks D, Lewis SW, Murray RM,. Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol Med 1993; 23: 591-604.
14. Kuperberg GR, Broome MR, McGuire PK,. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003; 60: 878-88.
15. DeLisi LE, Szulc KU, Bertisch HC, Majcher M, Brown K,. Understanding structural brain changes in schizophrenia. Dialogues Clin Neurosci 2006; 8: 71-8.
16. Palaniyappan L, Marques TR, Taylor H,. Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry 2013; 70: 1031-40.
17. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V,. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011; 68: 128-37.
18. Ren W, Lui S, Deng W,. Anatomical and functional brain abnormalities in drug-naive first-episode schizophrenia. Am J Psychiatry 2013; 170: 1308-16.
19. Selemon LD, Rajkowska G, Goldman-Rakic PS,. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comp Neurol 1998; 392: 402-12.
20. Glantz LA, Lewis DA,. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65-73.
21. Konopaske GT, Lange N, Coyle JT, Benes FM,. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry 2014; 71: 1323-31.
22. Sweet RA, Henteleff RA, Zhang W, Sampson AR, Lewis DA,. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 2009; 34: 374-89.
23. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA,. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 2001; 58: 466-73.
24. Rosoklija G, Toomayan G, Ellis SP,. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000; 57: 349-56.
25. Buckley PF, Friedman L, Jesberger JA, Schulz SC, Jaskiw G,. Head size and schizophrenia. Schizophr Res 2002; 55: 99-104.
26. Pakkenberg B,. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res 1992; 7: 95-100.
27. Young KA, Manaye KF, Liang C, Hicks PB, German DC,. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry 2000; 47: 944-53.
28. Shizukuishi T, Abe O, Aoki S,. Diffusion tensor imaging analysis for psychiatric disorders. Magn Reson Med Sci 2013; 12: 153-9.
29. Fitzsimmons J, Kubicki M, Shenton ME,. Review of functional and anatomical brain connectivity findings in schizophrenia. Curr Opin Psychiatry 2013; 26: 172-87.
30. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC,. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 2011; 70: 672-9.
31. Whitfield-Gabrieli S, Ford JM,. Default mode network activity and connectivity in psychopathology. Annu Rev Clin Psychol 2012; 8: 49-76.
32. Karbasforoushan H, Woodward ND,. Resting-state networks in schizophrenia. Curr Top Med Chem 2012; 12: 2404-14.
33. van den Heuvel MP, Mandl RC, Stam CJ, Kahn RS, Hulshoff Pol HE,. Aberrant frontal and temporal complex network structure in schizophrenia: a graph theoretical analysis. J Neurosci 2010; 30: 15915-26.
34. Young AB, Penney JB,. Neurochemical anatomy of movement disorders. Neurol Clin 1984; 2: 417-33.
35. Spokes EG,. GABA in Huntingtons chorea, Parkinsonism and schizophrenia. Adv Exp Med Biol 1979; 123: 461-73.
36. Seeman P,. Schizophrenia and dopamine receptors. Eur Neuropsychopharmacol 2013; 23: 999-1009.
37. Harrison PJ,. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593-624.
38. McNally JM, McCarley RW, Brown RE,. Impaired GABAergic neurotransmission in schizophrenia underlies impairments in cortical gamma band oscillations. Curr Psychiatry Rep 2013; 15: 346-55.
39. Hammond JC, McCullumsmith RE, Funk AJ, Haroutunian V, Meador-Woodruff JH,. Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Neuropsychopharmacology 2010; 35: 2110-9.
40. Crocq MA, Mant R, Asherson P,. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992; 29: 858-60.
41. Arinami T, Itokawa M, Enguchi H,. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 1994; 343: 703-4.
42. Weiss J, Mägert HJ, Cieslak A, Forssmann WG,. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls. Eur J Med Res 1996; 251: 439-45.
43. Sommer SS, Lind TJ, Heston LL, Sobell JL,. Dopamine D4 receptor variants in unrelated schizophrenic cases and controls. Am J Med Genet 1993; 48: 90-3.
44. Collins FS,. Sequencing the human genome. Hosp Pract 1997; 32: 35-43.
45. Millar JK, Wilson-Annan JC, Anderson S,. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415-23.
46. Vignal A, Milan D, SanCristobal M, Eggen A,. A review on SNP and other types of molecular markers and their use in animal genetics. Genet Sel Evol 2002; 34: 275-305.
47. Kirov G, Pocklington AJ, Holmans P,. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17: 142-53.
48. Vorstman JA, Breetvelt EJ, Thode KI, Chow EW, Bassett AS,. Expression of autism spectrum and schizophrenia in patients with a 22q11.2 deletion. Schizophr Res 2013; 143: 55-9.
49. Bergen SE, ODushlaine CT, Ripke S,. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 2012; 17: 880-6.
50. Green EK, Rees E, Walters JT,. Copy number variation in bipolar disorder. Mol Psychiatry 2016; 21: 89-93.
51. Neale BM, Sklar P,. Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation. Curr Opin Neurobiol 2015; 30: 131-8.
52. Pearlson GD, Garbacz DJ, Tompkins RH,. Clinical correlates of lateral ventricular enlargement in bipolar affective disorder. Am J Psychiatry 1984; 141: 253-6.
53. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-7.
54. Engert F, Bonhoeffer T,. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 1999; 399: 66-70.
55. Straub C, Sabatini BL,. How to grow a synapse. Neuron 2014; 82: 256-7.
56. Balu DT, Basu AC, Corradi JP, Cacace AM, Coyle JT,. The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex. Neurobiol Dis 2012; 45: 671-82.
57. Balu DT, Li Y, Puhl MD, Benneyworth MA,. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci USA 2013; 110: E2400-9.
58. Balu DT, Coyle JT,. Neuronal D-serine regulates dendritic architecture in the somatosensory cortex. Neurosci Lett 2012; 517: 77-81.
59. Balu DT, Coyle JT,. The NMDA receptor glycine modulatory site in schizophrenia: D-serine, glycine, and beyond. Curr Opin Pharmacol 2015; 20: 109-15.
60. Diez H, Garrido JJ, Wandosell F,. Specific roles of Akt iso forms in apoptosis and axon growth regulation in neurons. PLoS One 2012; 7: e32715.
61. Sakimura K, Kutsuwada T, Ito I,. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 1995; 373: 151-5.
62. Carlisle HJ, Fink AE, Grant SG, ODell TJ,. Opposing effects of PSD-93 and PSD-95 on long-term potentiation and spike timing-dependent plasticity. J Physiol 2008; 586: 5885-900.
63. Howard MA, Elias GM, Elias LA, Swat W, Nicoll RA,. The role of SAP97 in synaptic glutamate receptor dynamics. Proc Natl Acad Sci USA 2010; 107: 3805-10.
64. Schmitt WB, Sprengel R, Mack V,. Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice. Nat Neurosci 2005; 8: 270-2.
65. Fujioka R, Nii T, Iwaki A,. Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes. Mol Brain 2014; 7: 31-41.
66. Huang CH, Pei JC, Luo DZ, Chen C, Chen YW, Lai WS,. Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia. Front Behav Neurosci 2015; 8: 455-62.
67. Keefe RS,. Cognition and motivation as treatment targets in schizophrenia. JAMA Psychiatry 2014; 71: 987-8.
68. Keefe RS, Bilder RM, Harvey PD,. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006; 3: 2033-46.
69. Coyle JT, Balu D, Benneyworth M, Basu A, Roseman A,. Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues Clin Neurosci 2010; 12: 359-82.
70. Lisman JE, Coyle JT, Green RW,. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008; 31: 234-42.